from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2486/echA14

LFCtreatmentdescriptionclass of inhibitor

-0.497

Amikacinug/mL Amikacintranslation

1.186

Cap5-10ug/mL Capreomycintranslation

1.740

Rox10-50 ug/mL Roxithromycintranslation

-0.021

SM2-5 ug/mL Streptomycintranslation

0.198

Tet5-10 ug/mL Tetracyclinetranslation

-1.101

Rif0.2-5ug/mL Rifampicintranscription

0.062

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.328

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.913

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.476

CPZ10-50 ug/mL Chlorpromazinerespiration

1.108

Clofazimine10-13 ug/mL Clofaziminerespiration

0.187

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.218

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.584

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.350

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.884

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.408

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.233

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.240

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.384

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.127

KCN5-20 ug/mL Potassium cyaniderespiration

0.583

NaN30.2-2 mM Sodium aziderespiration

0.642

Nigericin50 uM Nigericinrespiration

-0.826

TRC10-150 ug/mL Triclosanrespiration

0.326

TRZ10-25 ug/mL Thioridazinerespiration

-0.836

Valinomycin0.5-10 uM Valinomycinrespiration

0.261

ZnSO42 mM ZnSO4respiration

0.610

menadione6-10 ug/mL Menadionerespiration

-0.432

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.394

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.081

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.220

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.373

NRP_1Non-replicating persistence stage 1dosRassociated

1.069

Amp0.2mg/mL AmpicillincellWall

0.246

Cephalexin20-100 ug/mL CephalexincellWall

0.106

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.045

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.075

EMB10-20 ug/mL EthambutolcellWall

-0.933

Eta12-40 ug/mL EthionamidecellWall

0.020

INH0.2-0.4 ug/mL IsoniazidcellWall

0.625

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.040

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.098

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.965

BZA0.12 mg/mL BenzamidearomaticAmides

0.036

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.196

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.427

H2O24 mM hydrogen peroxideDNAdamaging

0.219

Levo10 ug/mL LevofloxacinDNAdamaging

-0.054

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.270

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.511

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.494

UVUV-irradiationDNAdamaging

0.161

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.201

Antimycin12.5-50 ug/mL Antimycin A?

0.061

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.109

PA_110-50 ug/mL Antitubercular compound PA-1?

0.761

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.201

PA8240.2-2 ug/mL PA-824?

1.161

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.165

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.668

Verapamil50 uM Verapamil?

0.246

mercaptoethanol2 mM 2-Mercaptoethanol?

0.193

methoxatin10-20 ug/mL Methoxatin?